Definitive Healthcare (DH) Current Deferred Revenue (2020 - 2026)

Definitive Healthcare (DH) has reported Current Deferred Revenue for 7 consecutive years, with $89.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue fell 11.43% year-over-year to $89.3 million; the trailing twelve-month figure through Jun 2026 stood at $89.3 million (down 11.43% YoY), and the FY2025 full-year result was $97.0 million, up 3.9% from the prior year.
• Current Deferred Revenue declined to $89.3 million in Q2 2026 per DH's latest filing, from $99.1 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $109.7 million in Q1 2025 and bottomed at $83.8 million in Q3 2022.
• Historically, Current Deferred Revenue has averaged $96.0 million across 5 years, with a median of $97.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue gained 20.07% in 2022, then fell 11.43% in 2026.
• Over 5 years, Current Deferred Revenue stood at $99.7 million in 2022, then declined by 2.32% to $97.4 million in 2023, then slipped by 4.14% to $93.3 million in 2024, then increased by 3.9% to $97.0 million in 2025, then declined by 7.88% to $89.3 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $89.3 million, $99.1 million, and $97.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.